---
title: "Zero Bleeds for Takeda Pharmaceuticals"
description: "Explore Enso's partnership with Takeda Pharmaceuticals on the Zero Bleeds platform. Discover our innovative haemophilia patient app and HCP portal, enhancing treatment compliance and streamlining medical care globally."
url: https://www.enso.com.au/project/zero-bleeds
site: "Enso Studios"
modified: 2026-09-18
---

# Zero Bleeds for Takeda Pharmaceuticals

> Patient app and connected HCP portal

Client: [Takeda Pharmaceuticals](https://www.takeda.com)  
Capabilities: [App Development](https://www.enso.com.au/app-development), [Web Development and Content](https://www.enso.com.au/web-development-and-content), [Brand & Communication Design](https://www.enso.com.au/brand-communication-design), [Video Production & Animation](https://www.enso.com.au/video-production-animation)  
Services: Design and Development of Patient Mobile App, Design and Development of HCP Portal Web Application, User Experience and User Interface Design, Global AWS Deployment, Secure Patient Data Management, Validation as a Class 1 Software Medical Device, Language / Feature Localisations, Sales and Marketing Collateral, Animation

In partnership with Takeda, Enso designed, developed, and globally deployed the Zero Bleeds platform, consisting of a haemophilia patient mobile app, and a connected Haemophilia Treatment Center web application.

The intuitive patient-centric app assists with treatment compliance and record keeping, while providing secure real-time monitoring data to the treating physician. Physicians can configure patient specific alerts based on parameters such as compliance or bleed events, and easily update the patient’s prescription and infusion schedule remotely. In some regions the platform supports patient-initiated ordering of drug infusions and streamlines government/payer reporting.